-
1
-
-
66949117423
-
The scientific and clinical basis for the treatment of Parkinson disease (2009)
-
Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009). Neurology. 2009;72(21 suppl 4): S1-S136.
-
(2009)
Neurology
, vol.72
, Issue.21 SUPPL. 4
-
-
Olanow, C.W.1
Stern, M.B.2
Sethi, K.3
-
3
-
-
33745919520
-
Epidemiology of Parkinson's disease
-
de Lau LM, Breteler MM. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5(6):525-535.
-
(2006)
Lancet Neurol
, vol.5
, Issue.6
, pp. 525-535
-
-
de Lau, L.M.1
Breteler, M.M.2
-
4
-
-
78649293807
-
-
Scottish Intercollegiate Guidelines Network, Edinburgh: Scottish Intercollegiate Guidelines Network; January, Accessed March 8, 2011
-
Scottish Intercollegiate Guidelines Network. Diagnosis and Pharmacological Management of Parkinson's disease: A National Clinical Guideline. Edinburgh: Scottish Intercollegiate Guidelines Network; January 2010. http://www.sign.ac.uk/pdf/sign113.pdf. Accessed March 8, 2011.
-
(2010)
Diagnosis and Pharmacological Management of Parkinson's Disease: A National Clinical Guideline
-
-
-
5
-
-
73949149476
-
Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland
-
Newman EJ, Breen K, Patterson J, Hadley DM, Grosset KA, Grosset DG. Accuracy of Parkinson's disease diagnosis in 610 general practice patients in the West of Scotland. Mov Disord. 2009;24(16):2379-2385.
-
(2009)
Mov Disord
, vol.24
, Issue.16
, pp. 2379-2385
-
-
Newman, E.J.1
Breen, K.2
Patterson, J.3
Hadley, D.M.4
Grosset, K.A.5
Grosset, D.G.6
-
6
-
-
0036829811
-
How valid is the clinical diagnosis of Parkinson's disease in the community?
-
Schrag A, Ben-Shlomo Y, Quinn N. How valid is the clinical diagnosis of Parkinson's disease in the community? J Neurol Neurosurg Psychiatry. 2002;73(5):529-534.
-
(2002)
J Neurol Neurosurg Psychiatry
, vol.73
, Issue.5
, pp. 529-534
-
-
Schrag, A.1
Ben-Shlomo, Y.2
Quinn, N.3
-
7
-
-
79955950682
-
Differentiation and diagnosis of tremor
-
Crawford P, Zimmerman EE. Differentiation and diagnosis of tremor. Am Fam Physician. 2011;83(6):697-702.
-
(2011)
Am Fam Physician
, vol.83
, Issue.6
, pp. 697-702
-
-
Crawford, P.1
Zimmerman, E.E.2
-
8
-
-
29044435205
-
The diagnosis of Parkinson's disease
-
Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol. 2006;5(1):75-86.
-
(2006)
Lancet Neurol
, vol.5
, Issue.1
, pp. 75-86
-
-
Tolosa, E.1
Wenning, G.2
Poewe, W.3
-
9
-
-
33646082990
-
Practice parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66(7):968-975.
-
(2006)
Neurology
, vol.66
, Issue.7
, pp. 968-975
-
-
Suchowersky, O.1
Reich, S.2
Perlmutter, J.3
Zesiewicz, T.4
Gronseth, G.5
Weiner, W.J.6
-
10
-
-
0037438933
-
Does this patient have Parkinson disease?
-
Rao G, Fisch L, Srinivasan S, et al. Does this patient have Parkinson disease? JAMA. 2003;289(3):347-353.
-
(2003)
JAMA
, vol.289
, Issue.3
, pp. 347-353
-
-
Rao, G.1
Fisch, L.2
Srinivasan, S.3
-
11
-
-
33745988951
-
-
The National Collaborating Centre for Chronic Conditions, London: Royal College of Physicians, Accessed March 8, 2011
-
The National Collaborating Centre for Chronic Conditions. Parkinson's Disease: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care. London: Royal College of Physicians; 2006. http://www.nice.org.uk/nicemedia/live/10984/30087/30087.pdf. Accessed March 8, 2011.
-
(2006)
Parkinson's Disease: National Clinical Guideline For Diagnosis and Management In Primary and Secondary Care
-
-
-
12
-
-
41349114646
-
Dementia and survival in Parkinson disease: A 12-year population study
-
Buter TC, van den Hout A, Matthews FE, Larsen JP, Brayne C, Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008;70(13):1017-1022.
-
(2008)
Neurology
, vol.70
, Issue.13
, pp. 1017-1022
-
-
Buter, T.C.1
van den Hout, A.2
Matthews, F.E.3
Larsen, J.P.4
Brayne, C.5
Aarsland, D.6
-
13
-
-
42049114224
-
Parkinson disease and risk of mortality: A prospective comorbidity-matched cohort study
-
Driver JA, Kurth T, Buring JE, Gaziano JM, Logroscino G. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology. 2008;70(16 pt 2):1423-1430.
-
(2008)
Neurology
, vol.70
, Issue.16 Pt 2
, pp. 1423-1430
-
-
Driver, J.A.1
Kurth, T.2
Buring, J.E.3
Gaziano, J.M.4
Logroscino, G.5
-
14
-
-
23844437947
-
Prognosis of Parkinson disease: Risk of dementia and mortality: The Rotterdam Study
-
de Lau LM, Schipper CM, Hofman A, Koudstaal PJ, Breteler MM. Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol. 2005; 62(8):1265-1269.
-
(2005)
Arch Neurol
, vol.62
, Issue.8
, pp. 1265-1269
-
-
de Lau, L.M.1
Schipper, C.M.2
Hofman, A.3
Koudstaal, P.J.4
Breteler, M.M.5
-
15
-
-
0037039267
-
Practice parameter: Initiation of treatment for Parkinson's disease: An evidencebased review: Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Miyasaki JM, Martin W, Suchowersky O, Weiner WJ, Lang AE. Practice parameter: initiation of treatment for Parkinson's disease: an evidencebased review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2002; 58 (1): 11-17.
-
(2002)
Neurology
, vol.58
, Issue.1
, pp. 11-17
-
-
Miyasaki, J.M.1
Martin, W.2
Suchowersky, O.3
Weiner, W.J.4
Lang, A.E.5
-
17
-
-
77950179361
-
Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease
-
Caslake R, Macleod A, Ives N, Stowe R, Counsell C. Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease. Cochrane Database Syst Rev. 2009;(4):CD006661.
-
(2009)
Cochrane Database Syst Rev
, Issue.4
-
-
Caslake, R.1
Macleod, A.2
Ives, N.3
Stowe, R.4
Counsell, C.5
-
19
-
-
0035845719
-
The use of alternative therapies by patients with Parkinson's disease
-
Rajendran PR, Thompson RE, Reich SG. The use of alternative therapies by patients with Parkinson's disease. Neurology. 2001;57(5):790-794.
-
(2001)
Neurology
, vol.57
, Issue.5
, pp. 790-794
-
-
Rajendran, P.R.1
Thompson, R.E.2
Reich, S.G.3
-
20
-
-
33646104205
-
Practice parameter: Neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
published correction appears in Neurology. 2006;67(2):299
-
Suchowersky O, Gronseth G, Perlmutter J, Reich S, Zesiewicz T, Weiner WJ. Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology [published correction appears in Neurology. 2006;67(2):299]. Neurology. 2006;66(7):976-982.
-
(2006)
Neurology
, vol.66
, Issue.7
, pp. 976-982
-
-
Suchowersky, O.1
Gronseth, G.2
Perlmutter, J.3
Reich, S.4
Zesiewicz, T.5
Weiner, W.J.6
-
21
-
-
33646076457
-
Practice parameter: Treatment of Parkinson disease with motor fuctuations and dyskinesia (an evidencebased review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Pahwa R, Factor SA, Lyons KE, et al. Practice parameter: treatment of Parkinson disease with motor fuctuations and dyskinesia (an evidencebased review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66(7):983-995.
-
(2006)
Neurology
, vol.66
, Issue.7
, pp. 983-995
-
-
Pahwa, R.1
Factor, S.A.2
Lyons, K.E.3
-
22
-
-
84921705486
-
Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease
-
Deane KH, Spieker S, Clarke CE. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease. Cochrane Database Syst Rev. 2004;(4):CD004554.
-
(2004)
Cochrane Database Syst Rev
, Issue.4
-
-
Deane, K.H.1
Spieker, S.2
Clarke, C.E.3
-
23
-
-
77955501449
-
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson's disease patients with motor complications
-
Stowe R, Ives N, Clarke CE, et al. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson's disease patients with motor complications. Cochrane Database Syst Rev. 2010;(7): CD007166.
-
(2010)
Cochrane Database Syst Rev
, Issue.7
-
-
Stowe, R.1
Ives, N.2
Clarke, C.E.3
-
24
-
-
79951526730
-
Deep brain stimulation for Parkinson disease: An expert consensus and review of key issues
-
Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol. 2011; 68 (2): 165-171.
-
(2011)
Arch Neurol
, vol.68
, Issue.2
, pp. 165-171
-
-
Bronstein, J.M.1
Tagliati, M.2
Alterman, R.L.3
-
25
-
-
58149385649
-
CSP 468 Study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: A randomized controlled trial
-
Weaver FM, Follett K, Stern M, et al.; CSP 468 Study Group. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA. 2009;301(1):63-73.
-
(2009)
JAMA
, vol.301
, Issue.1
, pp. 63-73
-
-
Weaver, F.M.1
Follett, K.2
Stern, M.3
-
26
-
-
33748139412
-
German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson's disease
-
[published correction appears in N Engl J Med. 20 06;355 (12):1289]
-
Deuschl G, Schade-Brittinger C, Krack P, et al.; German Parkinson Study Group, Neurostimulation Section. A randomized trial of deep-brain stimulation for Parkinson's disease [published correction appears in N Engl J Med. 20 06;355 (12):1289]. N Engl J Med. 2006;355(9):896-908.
-
(2006)
N Engl J Med
, vol.355
, Issue.9
, pp. 896-908
-
-
Deuschl, G.1
Schade-Brittinger, C.2
Krack, P.3
-
27
-
-
53749108385
-
Parkinson Study Group ELLDOPA Investigators. Fatigue in levodopa-naive subjects with Parkinson disease
-
Schiftto G, Friedman JH, Oakes D, et al.; Parkinson Study Group ELLDOPA Investigators. Fatigue in levodopa-naive subjects with Parkinson disease. Neurology. 2008;71(7):481-485.
-
(2008)
Neurology
, vol.71
, Issue.7
, pp. 481-485
-
-
Schiftto, G.1
Friedman, J.H.2
Oakes, D.3
-
28
-
-
77950475028
-
Practice parameter: Treatment of nonmotor symptoms of Parkinson disease: Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Zesiewicz TA, Sullivan KL, Arnulf I, et al. Practice parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(11):924-931.
-
(2010)
Neurology
, vol.74
, Issue.11
, pp. 924-931
-
-
Zesiewicz, T.A.1
Sullivan, K.L.2
Arnulf, I.3
-
29
-
-
33748677085
-
Excessive daytime sleepiness in Parkinson disease: Is it the drugs or the disease?
-
Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen J.P. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology. 2006;67(5):853-858.
-
(2006)
Neurology
, vol.67
, Issue.5
, pp. 853-858
-
-
Gjerstad, M.D.1
Alves, G.2
Wentzel-Larsen, T.3
Aarsland, D.4
Larsen, J.P.5
-
30
-
-
80155208344
-
Associated factors for REM sleep behavior disorder in Parkinson disease
-
Sixel-Döring F, Trautmann E, Mollenhauer B, Trenkwalder C. Associated factors for REM sleep behavior disorder in Parkinson disease. Neurology. 2011;77 (11):1048-1054.
-
(2011)
Neurology
, vol.77
, Issue.11
, pp. 1048-1054
-
-
Sixel-Döring, F.1
Trautmann, E.2
Mollenhauer, B.3
Trenkwalder, C.4
-
31
-
-
27144469563
-
Rapid eye movement sleep parasomnias
-
Schenck CH, Mahowald MW. Rapid eye movement sleep parasomnias. Neurol Clin. 2005; 23 (4): 1107-1126.
-
(2005)
Neurol Clin
, vol.23
, Issue.4
, pp. 1107-1126
-
-
Schenck, C.H.1
Mahowald, M.W.2
-
32
-
-
77950927299
-
Glycopyrrolate for sialorrhea in Parkinson disease: A randomized, double-blind, crossover trial
-
Arbouw ME, Movig KL, Koopmann M, et al. Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial. Neurology. 2010;74(15):1203-1207.
-
(2010)
Neurology
, vol.74
, Issue.15
, pp. 1203-1207
-
-
Arbouw, M.E.1
Movig, K.L.2
Koopmann, M.3
-
33
-
-
14944354884
-
Sydney Multicenter Study of Parkinson's Disease: Non-L-dopa-responsive problems dominate at 15 years
-
Hely MA, Morris JG, Reid WG, Traffcante R. Sydney Multicenter Study of Parkinson's Disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord. 2005;20(2):190-199.
-
(2005)
Mov Disord
, vol.20
, Issue.2
, pp. 190-199
-
-
Hely, M.A.1
Morris, J.G.2
Reid, W.G.3
Traffcante, R.4
-
34
-
-
33646107153
-
Practice parameter: Evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology
-
Miyasaki JM, Shannon K, Voon V, et al. Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66(7):996-1002.
-
(2006)
Neurology
, vol.66
, Issue.7
, pp. 996-1002
-
-
Miyasaki, J.M.1
Shannon, K.2
Voon, V.3
-
35
-
-
64049105010
-
A controlled trial of antidepressants in patients with Parkinson disease and depression
-
Menza M, Dobkin RD, Marin H, et al. A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology. 2009;72(10):886-892.
-
(2009)
Neurology
, vol.72
, Issue.10
, pp. 886-892
-
-
Menza, M.1
Dobkin, R.D.2
Marin, H.3
|